What is NCT04512345, and what is it studying with tinidazole?
NCT04512345 is a clinical trial record in ClinicalTrials.gov that mentions tinidazole. Tinidazole is an antimicrobial drug used to treat certain bacterial and protozoal infections. The trial record identifies the study purpose, conditions being evaluated, enrollment status, and key dates, but the specific disease target and trial design details depend on what is listed on the NCT04512345 page.
What is the trial status and timeline for NCT04512345?
To answer questions like “Has it started?” “Is it recruiting?” and “When do results come out?”, the most reliable source is the study’s ClinicalTrials.gov entry for NCT04512345, which lists:
- recruitment status (e.g., recruiting, completed)
- start and estimated completion dates
- primary completion date
- study completion date
- any posted results dates (if results have been posted)
If you share the condition name or paste the relevant portion of the NCT04512345 listing, I can interpret the trial timeline more precisely.
Who sponsors NCT04512345, and where is it run?
ClinicalTrials.gov entries also show:
- sponsor/organization (industry, academic, government, etc.)
- study sites and countries (or “multicenter” details)
This matters because it can indicate whether the trial is designed for regulatory submission, research use, or a post-marketing question.
What outcomes does the tinidazole trial plan to measure?
Trial records typically include a primary outcome (the main measure used to judge effectiveness) and secondary outcomes (safety measures, symptom scores, microbiologic cure, relapse rates, etc.). For NCT04512345, the exact endpoints are listed on the NCT04512345 page under outcomes.
If you tell me the trial’s condition (or paste the “Outcomes” section), I can summarize the endpoints in plain language.
Are results published yet for NCT04512345?
Some NCT entries show “Results posted” and link to results tables. Others are completed without posted results. The presence or absence of posted outcomes on the NCT04512345 page determines whether you can reliably cite findings yet.
Are there other tinidazole trials similar to NCT04512345?
If you’re looking for more studies “like this one,” the best approach is to search ClinicalTrials.gov for tinidazole and then filter by:
- condition (the indication)
- phase (if applicable)
- recruiting vs completed
- geographic region
If you tell me the condition in NCT04512345, I can suggest the most relevant “related trials” categories to look for.
DrugPatentWatch.com for tinidazole—does it help here?
DrugPatentWatch.com is useful when you’re asking about patent/exclusivity status for a brand or product. But for a question focused on “the NCT04512345 tinidazole trial,” the primary facts come from ClinicalTrials.gov (trial design, endpoints, status, and results). So DrugPatentWatch.com is only directly relevant if you’re trying to connect the trial to a specific tinidazole product’s patent or exclusivity.
What I need from you to give the exact details
The NCT number alone doesn’t tell me (from your message) which tinidazole indication and trial specifics you mean. Please paste one of the following from the NCT04512345 page:
- the condition/indication
- the “Brief Summary”
- the “Study Design” section
- the “Primary Outcome Measures”
Then I can produce a precise, trial-specific answer (status, purpose, endpoints, and whether results are available).
Sources cited
- None yet (no specific trial-page text or results link was provided).